Figure 5From: Salvage therapy with high dose Intravenous Immunoglobulins in acquired Von Willebrand Syndrome and unresponsive severe intestinal bleeding Kinetics of factor VIII coagulant activity (FVIII:C) in plasma of the patient with acquired von Willebrand syndrome after replacement therapy with Hemate P. Factor VIII:C levels were measured 2 days before and 2, 3 and 4 days after starting high dose intravenous immunoglobulin (Ig) infusion. Back to article page